WitrynaImStem Biotechnology, Inc. is aspiring to revolutionize how serious diseases with significant unmet needs are treated with a new generation of regenerative and cellular therapies. Pioneering research led to the proprietary state-of … Witryna16 lis 2024 · AgeX sublicensed stem cell line ESI-053 to ImStem Biotechnology, Inc., a biopharmaceutical company developing embryonic stem cell (ESC)-derived mesenchymal stem cells (MSCs), for development of cell therapy candidate IMS001 for COVID-19 and acute respiratory distress syndrome (ARDS).
ImStem Biotechnology - Overview, News & Competitors
WitrynaImStem Biotechnology, Inc 385 obserwujących na LinkedIn. Imstem Biotechnology, Inc. is a biotechnology company focusing on developing cell therapeutic product derived from human pluripotent stem cells (hESC or iPSC) for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. With our … WitrynaImStem was incorporated in 2012. As an innovative biopharmaceutical company, we aspire to improve patients' treatment outcomes and quality of life, targeting areas in … cloudflare check nameservers
Embryonic stem cell-derived mesenchymal stem cells promote …
Witrynaimstem As a pioneer in regenerative medicine, we are constantly driven by science and technological innovation. We have successfully established the application platform … http://en.imstem.com.cn/ Witryna15 gru 2024 · Its development strategy focuses on neurologic, autoimmune, degenerative, and rare orphan diseases. ImStem Biotechnology Inc. is a privately held company headquartered in Farmington, CT. About IMS001 IMS001 is an investigational, allogeneic, MSC product derived from human embryonic stem cell line. byu ultimatium mother earth minerals